Eli Lilly's Largest Shareholder Files to Sell $347 Million in Stock

Key Facts

Eli Lilly's largest shareholder filed to sell approximately $347 million worth of stock. 24/7 Wall St. reported that the filing covers 300,000 shares and occurs as Wall Street analysts continue to raise their price targets for the pharmaceutical company.

LLY closed at $1,169.60 on October 8, 2026, having traded as low as $1,131.21 during that session. The divestment follows management raising 2026 revenue guidance to between $85 billion and $87 billion, while the proposed sale represents about 0.33% of the shareholder's total position of 90.37 million shares held as of June 30.